These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 32319016)
21. Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer. Noel CW; Stephens RF; Su JS; Xu W; Krahn M; Monteiro E; Goldstein DP; Giuliani M; Hansen AR; de Almeida JR Head Neck; 2020 Sep; 42(9):2277-2286. PubMed ID: 32333829 [TBL] [Abstract][Full Text] [Related]
22. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388 [TBL] [Abstract][Full Text] [Related]
23. Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L. Young TA; Mukuria C; Rowen D; Brazier JE; Longworth L Med Decis Making; 2015 Oct; 35(7):912-26. PubMed ID: 25997920 [TBL] [Abstract][Full Text] [Related]
24. Estimation of Health-Related Utilities for Soare IA; Leeuwenkamp O; Longworth L Pharmacoecon Open; 2021 Dec; 5(4):715-725. PubMed ID: 34260017 [TBL] [Abstract][Full Text] [Related]
25. Mapping algorithms from QLQ-C30 to EQ-5D utilities: no firm ground to stand on yet. Crott R Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):569-76. PubMed ID: 24910212 [TBL] [Abstract][Full Text] [Related]
26. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660 [TBL] [Abstract][Full Text] [Related]
27. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Versteegh MM; Leunis A; Luime JJ; Boggild M; Uyl-de Groot CA; Stolk EA Med Decis Making; 2012; 32(4):554-68. PubMed ID: 22114301 [TBL] [Abstract][Full Text] [Related]
28. Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained? Beck ACC; Kieffer JM; Retèl VP; van Overveld LFJ; Takes RP; van den Brekel MWM; van Harten WH; Stuiver MM PLoS One; 2019; 14(12):e0226077. PubMed ID: 31834892 [TBL] [Abstract][Full Text] [Related]
29. Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country. Yousefi M; Nahvijou A; Sari AA; Ameri H Value Health Reg Issues; 2021 May; 24():57-66. PubMed ID: 33508752 [TBL] [Abstract][Full Text] [Related]
30. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis. Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865 [TBL] [Abstract][Full Text] [Related]
31. Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France. Wojciechowski P; Wdowiak M; Hakimi Z; Wilson K; Fishman J; Nazir J; Toumi M J Comp Eff Res; 2023 May; 12(5):e220178. PubMed ID: 37052120 [No Abstract] [Full Text] [Related]
32. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Kay S; Ferreira A Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628 [TBL] [Abstract][Full Text] [Related]
33. Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. Crott R; Briggs A Eur J Health Econ; 2010 Aug; 11(4):427-34. PubMed ID: 20473703 [TBL] [Abstract][Full Text] [Related]
34. Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV. Joyce VR; Sun H; Barnett PG; Bansback N; Griffin SC; Bayoumi AM; Anis AH; Sculpher M; Cameron W; Brown ST; Holodniy M; Owens DK MDM Policy Pract; 2017; 2(2):2381468317716440. PubMed ID: 30288427 [No Abstract] [Full Text] [Related]
36. Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods. Crott R Pharmacoecon Open; 2018 Jun; 2(2):165-177. PubMed ID: 29623623 [TBL] [Abstract][Full Text] [Related]
37. Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. Meregaglia M; Borsoi L; Cairns J; Tarricone R Eur J Health Econ; 2019 Mar; 20(2):181-193. PubMed ID: 28948436 [TBL] [Abstract][Full Text] [Related]
38. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data. Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270 [TBL] [Abstract][Full Text] [Related]
39. A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches. Khan I; Morris S Health Qual Life Outcomes; 2014 Nov; 12():163. PubMed ID: 25388439 [TBL] [Abstract][Full Text] [Related]
40. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea. Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]